HIV-PROTEASEINHIBITOREN

Patent europeic · EP0695184 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP0695184
Numer da la dumonda
EP94907199
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
18-01-1994
Publitgà
07-02-1996
Concedì
21-04-1999
Stritgà
21-04-1999
Motiv
Nagin effect per la Svizra ed il Liechtenstein
Classas IPC
C07C 235/42 (2006.01)
C07C 235/66 (2006.01)
C07C 323/60 (2006.01)
C07C 323/63 (2006.01)
C07C 237/30 (2006.01)
C07C 323/62 (2006.01)
C07D 211/78 (2006.01)
C07D 213/74 (2006.01)
C07D 213/81 (2006.01)
C07D 215/08 (2006.01)
C07D 217/06 (2006.01)
A61K 31/165 (2006.01)
Prioritad
US 5150 15.01.1993
US 42261 02.04.1993
US 99375 30.07.1993
Dumonda PCT
PCT/US1994/000419 18.01.1994
Publicaziun PCT
WO1994/015608 21.07.1994
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 29-10-1999

    Midada

    Published in PIDTJ No 20 in 1999

  2. 30-04-1999

    Concedì

    Published in PIDTJ No 8 in 1999

Partidas

Possessur

Agouron Pharmaceuticals, Inc.

AGOURON PHARMACEUTICALS, INC.

3565 General Atomics Court, San Diego, CA 92121, US

Inventur

REICH, Siegfried, H.

San Diego, CA 92104, US

LEWIS, Kathleen

San Diego, CA 92129, US

MELNICK, Michael

San Diego, CA 92111, US

FUHRY, Mary Ann M.

APO AEO 9459, US

KALDOR, Stephen, Warren

Indianapolis, IN 46254, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.